TREM2 Is a Receptor for ß-Amyloid that Mediates Microglial Function.
Neuron
; 97(5): 1023-1031.e7, 2018 03 07.
Article
em En
| MEDLINE
| ID: mdl-29518356
ABSTRACT
Mutations in triggering receptor expressed on myeloid cells 2 (TREM2) have been linked to increased Alzheimer's disease (AD) risk. Neurobiological functions of TREM2 and its pathophysiological ligands remain elusive. Here we found that TREM2 directly binds to ß-amyloid (Aß) oligomers with nanomolar affinity, whereas AD-associated TREM2 mutations reduce Aß binding. TREM2 deficiency impairs Aß degradation in primary microglial culture and mouse brain. Aß-induced microglial depolarization, K+ inward current induction, cytokine expression and secretion, migration, proliferation, apoptosis, and morphological changes are dependent on TREM2. In addition, TREM2 interaction with its signaling adaptor DAP12 is enhanced by Aß, regulating downstream phosphorylation of SYK and GSK3ß. Our data demonstrate TREM2 as a microglial Aß receptor transducing physiological and AD-related pathological effects associated with Aß.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Encéfalo
/
Glicoproteínas de Membrana
/
Receptores Imunológicos
/
Peptídeos beta-Amiloides
/
Microglia
/
Doença de Alzheimer
Idioma:
En
Ano de publicação:
2018
Tipo de documento:
Article